Advertisement

Topics

Cell Therapies Pty Ltd Company Profile

08:49 EST 20th November 2017 | BioPortfolio

Cell Therapies Pty Ltd is in the business of planning and conducting clinical trials that involve the collection, manipulation and storage of blood cells and human tissue. The services range from laboratory rental through to fully-integrated planning and execution of clinical trials that involve cellular therapeutics manufactured in code of Good Manufacturing Practice (cGMP) and Therapeutic Goods Administration (TGA) licensed facilities.

Location

105 Highgrove Drive
Chapel Hill
North Carolina
United States of America

Contact

Phone: (919) 969 1130
Email: Miles.Prince@petermac.org


News Articles [1632 Associated News Articles listed on BioPortfolio]

Chimeric antigen receptor T-cell therapies for lymphoma

Cell-based immunotherapies are showing great promise in the treatment of even the most treatment-refractory of haematological malignancies. Herein, Jennifer Brudno and James Kochenderfer review the re...

T-cell therapies: Part 2 () - What comes after CD19 CAR?

Edison Investment Research - Pharmaceutical & healthcare - T‐cell cancer therapies: This report forms Part 2 of a detailed review of T-cell therapies. It gives a more detailed and scientific ove...

Commission demands reform on experimental cell therapies

The reputation of stem cell research is being undermined by unscrupulous clinics offering unproven therapies, says a report published last week...

T‐cell cancer therapies: Part 1 () - Looking beyond CD19 for the next opportunities

Edison Investment Research - Pharmaceutical & healthcare - T‐cell cancer therapies: CD19 CAR-T therapy gives dramatic responses in some B-cell cancers covering 1.4% of US cancers and about 1% of...

New man-made antioxidant could help improve success rates of cell-based therapies

Cell therapies being developed to treat a range of conditions could be improved by a chemical compound that aids their survival, research suggests.

Cell and gene therapies offer promise, but face market access challenges

In light of the progress and potential of cell and gene therapies, Amy Grogg, senior vice president of…

FDA to enforcement oversight of stem cell therapies and regenerative medicine

One of the most promising new fields of science and medicine is the area of cell therapies and their use in regenerative medicine. These new technologies, most of which are in early stages of developm...

Servier, Transgene Leverage Platform Tech for More Effective CAR T-Cell Therapies

Servier and Transgene have established a research collaboration to evaluate the latter’s viral vectorization technologies for use in engineering allogeneic chimeric antigen receptor (CAR) T-cell the...

Drugs and Medications [36 Associated Drugs and Medications listed on BioPortfolio]

Cladribine [Onco Therapies Limited ]

Cladribine Injection

Zolinza [Merck Sharp & Dohme Corp.]

These highlights do not include all the information needed to use ZOLINZA safely and effectively. See full prescribing information for ZOLINZA. ZOLINZA® (vorinostat) CapsulesInitial U.S. Approval: 20...

Humira [Abbott Laboratories]

These highlights do not include all the information needed to use HUMIRA safely and effectively. See full prescribing information for HUMIRA.HUMIRA (adalimumab) Injection, Solution for Subcutaneous us...

Sun care [Zenith Medicosm SL]

Drug Facts

Sun care [Zenith Medicosm SL]

Drug Facts

PubMed Articles [3757 Associated PubMed Articles listed on BioPortfolio]

"Monoclonal antibodies in the treatment of MS: emergence of B-cell targeted therapies".

Multiple sclerosis (MS) is a chronic inflammatory disease of the CNS, and one of the most common causes of disability in young adults. Over the last decade, new disease modifying therapies have rapidl...

An engineered biomarker system to monitor and modulate immune clearance of cell therapies.

Cell transplants offer a new opportunity to deliver therapies with novel and complex mechanisms of action. Understanding the pharmacology of cell transplants is important to deliver this new therapy e...

Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group study.

Treatment of non-clear cell renal cell carcinoma (RCC) remains controversial despite several recent prospective studies of targeted therapies (TT). Often Vascular Endothelial growth Factor (VEGF) and ...

Stem Cell Smart Technology, where are we now and how far we have to go?

Approximately eight million people in the United States have peripheral arterial disease, which increases exponentially with age. There have been a plethora of available treatments including surgery, ...

Understanding current therapies in metastatic melanoma.

Cutaneous melanoma is a highly aggressive tumor developing from melanocytes, its incidence is increasing, and prognosis in advanced stages is daunting. New therapies have been approved during the rece...

Clinical Trials [6705 Associated Clinical Trials listed on BioPortfolio]

Tracking Peripheral Blood Mononuclear Cells With Fluorine MRI

Cell-based therapies in the form of stem cell-based or immune cell-based therapies are becoming important treatment options that are either approved for clinical use or are showing promise...

Perceptions of Cell and Gene Therapies (CGT) for the Treatment of Cancer

Gene and cell therapies have a real value potential (example: potential long-term effect, curative potential, and single administration) but also drawbacks (example: treatment perceived as...

Phase Ib/II Trial of Interleukin-2 and PD-1 Checkpoint Inhibitor, Nivolumab In Metastatic Clear Cell Renal Cell Cancer

This will be a single arm, multi-site phase Ib/II clinical trial of standard doses of High Dose Interleukin-2 (HD IL2) (600,000 IU/kg/dose intravenously during two 5-day cycles 9 days apar...

Validation of a Predictive Nomogram of Response or Resistance to Targeted Therapies in Metastatic Clear Cell Renal Cell Carcinoma

The purpose of this study is to validate of a predictive nomogram of response or resistance to targeted therapies in metastatic clear cell renal cell carcinoma

Treatment of Chronic Lymphocytic Leukemia

CLL is a disease of the elderly, identifying effective therapies with better toxicity profiles is thus a high priority, and targeted therapies may allow attainment of this goal.

Companies [1647 Associated Companies listed on BioPortfolio]

Beike Biotechnology Company Limited

Beike Biotechnology (http://www.beikebiotech.com) is Asia's leading biotechnology company focusing on adult stem cell therapies. Beike's scientists have been focused on the development and commerc...

Beike Biotechnology Co. Ltd.

Beike Biotechnology (http://www.beikebiotech.com ) is China's leading biotechnology company focusing on adult stem cell therapies. Beike's scientists have been focused on the development and comme...

Opexa Therapeutics

Opexa Therapeutics is a commercialization driven biotechnology cellular therapy company that develops autologous personalized cell therapies for the treatment of various diseases. The Company is focus...

WuXi AppTec

WuXi AppTec’s U.S. Manufacturing and Testing group provides a comprehensive range of integrated programs for biologics, advanced therapies and medical devices – along wi...

Cell Therapies Pty Ltd

Cell Therapies Pty Ltd is in the business of planning and conducting clinical trials that involve the collection, manipulation and storage of blood cells and human tissue. The services range from labo...

More Information about "Cell Therapies Pty Ltd" on BioPortfolio

We have published hundreds of Cell Therapies Pty Ltd news stories on BioPortfolio along with dozens of Cell Therapies Pty Ltd Clinical Trials and PubMed Articles about Cell Therapies Pty Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cell Therapies Pty Ltd Companies in our database. You can also find out about relevant Cell Therapies Pty Ltd Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record